These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31588378)

  • 1. Δ
    Taskar PS; Patil A; Lakhani P; Ashour E; Gul W; ElSohly MA; Murphy B; Majumdar S
    Transl Vis Sci Technol; 2019 Sep; 8(5):15. PubMed ID: 31588378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surfactant concentration and sterilization process on intraocular pressure-lowering activity of Δ
    Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S
    Drug Deliv Transl Res; 2021 Oct; 11(5):2096-2107. PubMed ID: 33169348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mucoadhesive agent inclusion on the intraocular pressure lowering profile of Δ
    Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S
    Int J Pharm; 2022 Mar; 616():121564. PubMed ID: 35151817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism - based translational pharmacokinetic - pharmacodynamic model to predict intraocular pressure lowering effect of drugs in patients with glaucoma or ocular hypertension.
    Durairaj C; Shen J; Cherukury M
    Pharm Res; 2014 Aug; 31(8):2095-106. PubMed ID: 24549827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma.
    Lanzi C; Lucarini L; Durante M; Sgambellone S; Pini A; Catarinicchia S; Łażewska D; Kieć-Kononowicz K; Stark H; Masini E
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
    Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
    Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits.
    Pate DW; Järvinen K; Urtti A; Jarho P; Järvinen T
    Curr Eye Res; 1995 Sep; 14(9):791-7. PubMed ID: 8529418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of separate and combined topical treatment with timolol maleate and trifluormethazolamide on the intraocular pressure in normal rabbits.
    Bar-Ilan A
    Curr Eye Res; 1984 Nov; 3(11):1305-12. PubMed ID: 6542484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure.
    Lorenzo-Soler L; Olafsdottir OB; Garhöfer G; Jansook P; Kristinsdottir IM; Tan A; Loftsson T; Stefansson E
    Acta Ophthalmol; 2021 Jun; 99(4):376-382. PubMed ID: 33191620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.
    Clement Freiberg J; von Spreckelsen A; Kolko M; Azuara-Blanco A; Virgili G
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013817. PubMed ID: 35686679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release timolol maleate loaded ocusert based on biopolymer composite.
    Nair RV; S S; Suresh A; K R A; Nair SC
    Int J Biol Macromol; 2018 Apr; 110():308-317. PubMed ID: 29341922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A challenge to primary open-angle glaucoma including normal-pressure. Clinical problems and their scientific solution].
    Sugiyama K
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):233-67; discussion 268. PubMed ID: 22568103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs.
    Bastia E; Toris CB; Brambilla S; Galli C; Almirante N; Bergamini MVW; Masini E; Sgambellone S; Unser AM; Ahmed F; Torrejon KY; Navratil T; Impagnatiello F
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):17. PubMed ID: 33704360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.